Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:868-877

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weintraub, W. S.
Right arrow Articles by Craver, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weintraub, W. S.
Right arrow Articles by Craver, J. M.

(Circulation. 1997;95:868-877.)
© 1997 American Heart Association, Inc.


Articles

Outcome of Reoperative Coronary Bypass Surgery Versus Coronary Angioplasty After Previous Bypass Surgery

William S. Weintraub, MD; Ellis L. Jones, MD; Douglas C. Morris, MD; Spencer B. King, III, MD; Robert A. Guyton, MD; Joseph M. Craver, MD

the Divisions of Cardiology and Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Ga.

Correspondence to William S. Weintraub, MD, Division of Cardiology, Emory University Hospital 1365, Clifton Rd NE, Atlanta, GA 30322. E-mail bill@hp3.eushc.org.

Background The immediate and long-term outcomes of reoperative coronary artery bypass surgery (CABG) (n=1561) and catheter-based coronary intervention (angioplasty) (n=2613) were compared in patients from Emory University Hospitals who had previous CABG.

Methods and Results The surgical and angioplasty procedures and statistical methods were standard. Data were collected prospectively and entered into a computerized database. Follow-up was by letter, telephone, or additional events resulting in readmission. In the angioplasty group, 2.9% required in-hospital CABG. Hospital mortality was 1.2% after angioplasty versus 6.8% after repeat CABG (P<.0001). Recurrent angina was noted frequently at about 4 years and was more common after angioplasty. One-, 5-, and 10-year mortalities were 11%, 24%, and 49% after CABG versus 6%, 22%, and 38% after angioplasty. Survival corrected for baseline differences did not vary with the choice of procedure. There were more additional procedures after angioplasty. Patients undergoing angioplasty may be divided into those with procedures only in native coronary arteries (n=1545), only in vein grafts (n=869), and a mixture (n=199), with respective 10-year survivals of 66%, 56%, and 65% (P<.0001).

Conclusions These patients have a high incidence of events both in-hospital and in the long term. Although initial mortality was higher after CABG, after baseline differences were accounted for, there was no difference in the long term. Patients more frequently have additional procedures after angioplasty. Choice of therapy should consider clinical and angiographic suitability and patient preference.


Key Words: bypass • angioplasty • surgery




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. Garcia-Tejada, M. Velazquez, F. Hernandez, A. Albarran, S. Rodriguez, I. Gomez, J. Andreu, and J. Tascon
Percutaneous Revascularization of Grafts Versus Native Coronary Arteries in Postcoronary Artery Bypass Graft Patients
Angiology, February 1, 2009; 60(1): 60 - 66.
[Abstract] [PDF]


Home page
J Am Coll Cardiol IntvHome page
D. J. Kereiakes, M. A. Turco, J. Breall, N. Z. Farhat, R. L. Feldman, B. McLaurin, J. J. Popma, L. Mauri, P. Zimetbaum, J. Massaro, et al.
A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft Lesions: Results of the AMEthyst Randomized Controlled Trial
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Liao, D. F. Kong, L. K. Shaw, M. H. Sketch Jr, C. A. Milano, K. L. Lee, and D. B. Mark
A New Anatomic Score for Prognosis After Cardiac Catheterization in Patients with Previous Bypass Surgery
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1684 - 1692.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Cohen, S. A. Murphy, D. S. Baim, T. A. Lavelle, R. H. Berezin, D. E. Cutlip, K. K.L. Ho, R. E. Kuntz, and the SAFER Trial Investigators
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: Results from the SAFER trial
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1801 - 1808.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. P. Kelley, B. D. Klugherz, S. M. Hashemi, N. F. Meneveau, J. M. Johnston, W. H. Matthai Jr, V. S. Banka, H. C. Herrmann, J. W. Hirshfeld Jr, S. E. Kimmel, et al.
One-year clinical outcomes of protected and unprotected left main coronary artery stenting
Eur. Heart J., September 1, 2003; 24(17): 1554 - 1559.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Stankovic, A. Colombo, P. Presbitero, F. van den Branden, L. Inglese, C. Cernigliaro, L. Niccoli, A. L. Bartorelli, P. Rubartelli, N. Reifart, et al.
Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial
Circulation, July 8, 2003; 108(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. Cole, E. L. Jones, J. M. Craver, R. A. Guyton, D. C. Morris, J. S. Douglas Jr, Z. Ghazzal, and W. S. Weintraub
Outcomes of repeat revascularization in diabetic patients with prior coronary surgery
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1968 - 1975.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian
Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y Otsuka, S Miyazaki, H Okumura, S Yasuda, S Daikoku, I Morii, Y Sutani, Y Goto, and H Nonogi
Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty
Eur. Heart J., November 1, 2000; 21(21): 1790 - 1796.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Yamaguchi, H. Adachi, T. Ino, and Y. Kobayashi
Three-dimensional computed tomographic angiography as preoperative evaluation of a patent internal thoracic artery graft
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 811 - 812.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Choussat, A. J. R. Black, I. Bossi, T. Joseph, J. Fajadet, and J. Marco
Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 387 - 394.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Mathew, D. E. Grill, C. G. Scott, J. A. Grantham, H. H. Ting, K. N. Garratt, and D. R. Holmes Jr.
The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1163 - 1169.
[Abstract] [Full Text] [PDF]